Published in J Neurol on January 01, 2005
Ethical, legal, and social dimensions of epilepsy genetics. Epilepsia (2006) 5.95
Analysis of genetically complex epilepsies. Epilepsia (2005) 1.58
Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2008) 0.97
Altered language processing in autosomal dominant partial epilepsy with auditory features. Neurology (2008) 0.80
Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects. Mol Syndromol (2016) 0.76
Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet (2002) 3.73
Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet (1995) 2.72
Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum Mol Genet (2002) 2.65
Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol (1999) 1.65
LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol (2002) 1.48
Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology (2000) 1.44
Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia (2002) 1.21
Familial temporal lobe epilepsy with aphasic seizures and linkage to chromosome 10q22-q24. Epilepsia (2002) 1.09
Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol (2003) 1.02
Autosomal dominant partial epilepsy with auditory features: description of a new family. Epilepsia (2000) 0.94
Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology (2003) 0.91
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell (1991) 17.00
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
Triplet repeat mutations in human disease. Science (1992) 3.35
Characterization of a murine gene expressed from the inactive X chromosome. Nature (1991) 3.21
Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75
Polarization of the human motor cortex through the scalp. Neuroreport (1998) 2.72
Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet (1994) 2.68
Pachydermoperiostosis: an update. Clin Genet (2005) 2.65
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
The pathophysiology of primary dystonia. Brain (1998) 2.51
Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (1993) 2.45
Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr (1999) 2.18
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun (1995) 2.06
Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol (2000) 1.98
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89
Pentanucleotide repeat length polymorphism at the human CD4 locus. Nucleic Acids Res (1991) 1.85
22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet (1995) 1.82
Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype. Am J Med Genet (1994) 1.73
Facilitation of muscle evoked responses after repetitive cortical stimulation in man. Exp Brain Res (1998) 1.71
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
Incidence and predictors of acute symptomatic seizures after stroke. Neurology (2011) 1.68
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem (2001) 1.62
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA (1993) 1.58
Descending volley after electrical and magnetic transcranial stimulation in man. Neurosci Lett (1990) 1.54
The phenotype of partial dup(7q) reconsidered: a report of five new cases. Clin Genet (1988) 1.54
Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet (2003) 1.53
Cortical mechanisms mediating the inhibitory period after magnetic stimulation of the facial motor area. Muscle Nerve (1997) 1.52
Atrioventricular canal defect and postaxial polydactyly indicating phenotypic overlap of Ellis-van Creveld and Kaufman-McKusick syndromes. Pediatr Cardiol (1997) 1.52
Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol (1999) 1.50
Two high throughput technologies to detect segmental aneuploidies identify new Williams-Beuren syndrome patients with atypical deletions. J Med Genet (2005) 1.48
Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain (1992) 1.48
NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47
Linkage relationships between Retinoschisis, Xg, and a cloned DNA sequence from the distal short arm of the X chromosome. Hum Genet (1983) 1.47
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci (1997) 1.46
Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem (2001) 1.46
Jeune syndrome associated with cystinuria: report of two sisters. Am J Med Genet (1990) 1.43
Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Hum Genet (1989) 1.43
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43
The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes (2001) 1.42
Individual haploinsufficient loci and the complex phenotype of DiGeorge syndrome. Mol Med Today (2000) 1.41
Prenatal diagnosis of triose phosphate isomerase deficiency. Lancet (1989) 1.40
Single-joint rapid arm movements in normal subjects and in patients with motor disorders. Brain (1996) 1.39
Noonan syndrome with cardiac left-sided obstructive lesions. Hum Genet (1997) 1.39
A locus for autosomal dominant keratoconus maps to human chromosome 3p14-q13. J Med Genet (2004) 1.36
Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet (2004) 1.35
[Familial translocation 2-D]. Ann Genet (1968) 1.35
Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes. J Med Genet (1999) 1.35
SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics (1997) 1.34
Corticospinal potentials after transcranial stimulation in humans. J Neurol Neurosurg Psychiatry (1989) 1.33
Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32
Familial deletions of chromosome 22q11. Am J Med Genet (1997) 1.29
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet (1999) 1.24
Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res (1996) 1.24
Evidence for interaction between psoriasis-susceptibility loci on chromosomes 6p21 and 1q21. Am J Hum Genet (1999) 1.21
Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology (1992) 1.20
Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc Natl Acad Sci U S A (2005) 1.19
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Pathophysiology of hemimasticatory spasm. J Neurol Neurosurg Psychiatry (1994) 1.18
Deep brain stimulation of subthalamic nuclei affects arm response inhibition in Parkinson's patients. Cereb Cortex (2011) 1.14
UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet (1997) 1.13
Cortical and cervical stimulation after hemispheric infarction. J Neurol Neurosurg Psychiatry (1987) 1.13
New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle. Clin Genet (2010) 1.12
Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials. Clin Neurophysiol (2000) 1.12
Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain (1995) 1.12
Functional organization of the trigeminal motor system in man. A neurophysiological study. Brain (1989) 1.12
Transcranial magnetic stimulation techniques in clinical investigation. Neurology (2002) 1.11
Interstitial deletion 13q syndromes: a report on two unrelated patients. Hum Genet (1979) 1.10
Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet (2007) 1.10
Congenital heart defects in Kabuki syndrome. Am J Med Genet (2001) 1.09
Brainstem reflex circuits revisited. Brain (2004) 1.09
Meiotic drive at the myotonic dystrophy locus. J Med Genet (1994) 1.08
Complete transposition of the great arteries: patterns of congenital heart disease in familial precurrence. Circulation (2001) 1.08
BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes. Proc Natl Acad Sci U S A (2005) 1.08
Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview. Am J Med Genet (1985) 1.08
The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology (2005) 1.08
RASopathies: Clinical Diagnosis in the First Year of Life. Mol Syndromol (2011) 1.07
Chromosomal microarray as first-tier approach in low-risk pregnancies: detection rate should not be the only criterion for its application. Ultrasound Obstet Gynecol (2014) 1.07
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Cardiac malformations in patients with oral-facial-skeletal syndromes: clinical similarities with heterotaxia. Am J Med Genet (1999) 1.06
Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol (1999) 1.06
Differential block of conduction of larger fibers in peripheral nerve by direct current. Arch Ital Biol (1970) 1.06
Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain (1996) 1.06
Blink reflex and the masseter inhibitory reflex in patients with dystonia. Mov Disord (1993) 1.05
Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy. J Clin Invest (1994) 1.05
The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men. J Med Genet (2003) 1.04
Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Ther (2001) 1.03
RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders. Clin Genet (2008) 1.03